United States · FDA National Drug Code directory
Cefazolin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-3450_05cd44b2-275f-44f5-b4f8-22393df834a1
- Product NDC
- 0781-3450
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Cefazolin
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19881209
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFAZOLIN SODIUM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →